369 related articles for article (PubMed ID: 32932796)
1. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis.
Lee CH; Fu Y; Yang SJ; Chi CC
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932796
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Yan JH; Guan BJ; Gao HY; Peng XE
Medicine (Baltimore); 2018 Sep; 97(37):e12271. PubMed ID: 30212963
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
Guo XF; Yang B; Tang J; Li D
Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
Chen LH; Wang YF; Xu QH; Chen SS
Clin Nutr; 2018 Apr; 37(2):516-521. PubMed ID: 28040302
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis.
Shi XY; Fan SM; Shi GM; Yao J; Gao Y; Xia YG; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20624. PubMed ID: 32541499
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis.
Musazadeh V; Karimi A; Malekahmadi M; Ahrabi SS; Dehghan P
Clin Exp Pharmacol Physiol; 2023 May; 50(5):327-334. PubMed ID: 36692292
[TBL] [Abstract][Full Text] [Related]
10. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: an up-to-date systematic review and meta-analysis.
Vahdaninia M; Mackenzie H; Dean T; Helps S
Eur J Nutr; 2019 Oct; 58(7):2597-2613. PubMed ID: 30251019
[TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids.
de Castro GS; Calder PC
Clin Nutr; 2018 Feb; 37(1):37-55. PubMed ID: 28139281
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease.
Musa-Veloso K; Venditti C; Lee HY; Darch M; Floyd S; West S; Simon R
Nutr Rev; 2018 Aug; 76(8):581-602. PubMed ID: 29917092
[TBL] [Abstract][Full Text] [Related]
15. Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Lu W; Li S; Li J; Wang J; Zhang R; Zhou Y; Yin Q; Zheng Y; Wang F; Xia Y; Chen K; Liu T; Lu J; Zhou Y; Guo C
Gastroenterol Res Pract; 2016; 2016():1459790. PubMed ID: 27651787
[TBL] [Abstract][Full Text] [Related]
16. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.
Di Minno MN; Russolillo A; Lupoli R; Ambrosino P; Di Minno A; Tarantino G
World J Gastroenterol; 2012 Nov; 18(41):5839-47. PubMed ID: 23139599
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
19. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Parker HM; Johnson NA; Burdon CA; Cohn JS; O'Connor HT; George J
J Hepatol; 2012 Apr; 56(4):944-51. PubMed ID: 22023985
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.
Moore E; Patanwala I; Jafari A; Davies IG; Kirwan RP; Newson L; Mazidi M; Lane KE
Nutr Rev; 2024 Jan; 82(2):143-165. PubMed ID: 37290426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
